Investors

Delivering sustainable growth and value for our shareholders

Financial highlights 2024

Strong performance across all key financial metrics

Revenue

£156.2m

+8.5%

Gross Profit

£98.4m

+12.3%

Operating Profit

£42.1m

+6.8%

EPS

8.2p

+9.1%

Financial KPIs

View our key performance indicators and financial metrics.

View KPIs

Results centre

Access annual reports, presentations, and financial statements.

View results

Financial calendar

Stay informed about upcoming results announcements and events.

View calendar

Latest investor news

January 20, 2025 Trading Update

Q4 2024 Trading Update

primoraPharma announces strong Q4 performance with revenue growth across all key markets.

Read more
December 15, 2024 Results

Full Year Results 2024

primoraPharma reports record full year results with significant growth in international markets.

Read more
November 28, 2024 Announcement

Strategic Partnership Agreement

primoraPharma announces new strategic partnership to expand distribution in Southeast Asia.

Read more
View All News

Investor relations contact

For investor inquiries, please contact our investor relations team.

info@primorapharma.co.uk
+44 (0)20 7946 0958

65-70 Shelton Street

Covent Garden

65-70 Shelton street, Covent garden, London, united kingdom, WC4H 9JQ

WC2H 9JQ

Email alerts

Subscribe to receive regulatory news and investor updates.